FIELD: medicine.
SUBSTANCE: preparation for parenteral administration contains a pharmaceutically acceptable salt of methylethyl pyridinol, which additionally contains riboflavin and has a composition, g/100 ml: methylethyl pyridinol hydrochloride or succinate 1.0-5.0; riboflavin 0.002-0.05; water for injections up to 100 ml.
EFFECT: improving properties.
3 cl, 3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| EYE DROPS BASED ON COMPOSITION OF PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND METHYLETHYL PYRIDONOL AND TAURINE CONTAINING COMPOSITION OF GROUP B VITAMINS | 2013 |
|
RU2533276C1 |
| SYNERGETIC PREPARATION FOR TREATING CARDIOVASCULAR DISEASES, DIABETES MELLITUS AND HEPATOBILIARY DISEASES | 2012 |
|
RU2493841C1 |
| EYE DROPS BASED ON PHARMACEUTICALLY TOLERABLE ADDITIVE SALTS OF ACID AND METHYL ETHYL ENCEPHABOL CONTAINING COMPOSITION OF VITAMINS B | 2013 |
|
RU2528912C1 |
| ANTIOXIDANT PREPARATION FOR TREATING AND PREVENTING NEUROLOGICAL PATHOLOGIES IN ANIMALS | 2023 |
|
RU2813928C1 |
| SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
| N-VINYLPYRROLIDONE-BASED COPOLYMERS IN FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS OF ACIDS | 2013 |
|
RU2533113C1 |
| COMBINED OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING POLYHEXAMETHYLENE GUANIDINE AND TAURINE | 2012 |
|
RU2513997C1 |
| DISULFIRAM AND TAURINE-CONTAINING OPHTHALMOLOGICAL MEDICATION IN FORM OF EYE DROPS | 2012 |
|
RU2485939C1 |
| METHOD FOR PREPARING BIOLOGICALLY ACTIVE NANOLIQUID OF FERRIC OXIDE (II, III) NANOPARTICLES AND 3-HYDROXY PYRIDINE DERIVATIVE | 2012 |
|
RU2493857C1 |
| HIGH-STABLE PHARMACEUTICAL FORMULATION OF LYOPHILISATE OF 3-OXYPYRIDINE AND METHYLPYRIDINE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2012 |
|
RU2504376C1 |
